Relationship between membrane transport of methotrexate and endogenous cyclic adenosine 3'

5'-monophosphate in the Ehrlich ascites tumor

J. C. White, R. A. Carchman, D. W. Fry, I. David Goldman

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Transport of methotrexate in mammalian cells is a complex process. Although the drug is pumped uphill into cells, metabolic poisons enhance influx and transmembrane gradients for this agent. Structurally unrelated inorganic and organic anions nonspecifically depress these parameters in a variety of tumor cells. It has been suggested that cell cyclic adenosine 3':5'-monophosphate (cyclic AMP) plays a regulatory role in the transport of this agent. To evaluate this further, a number of different experimental approaches were used to analyze the relationship between methotrexate transport and cell cyclic AMP in the Ehrlich ascites tumor. The following results indicate that for the Ehrlich ascites tumor, at least, there is no evidence for a regulatory role for cyclic AMP in the transport of methotrexate. A marked increase in cell cyclic AMP by cholera toxin or reduction in cyclic AMP by ascorbate was unaccompanied by changes in methotrexate influx. Instantaneous and constant inhibition of methotrexate influx by isobutylmethylxanthine was temporally dissociated from the slower rise in cell cyclic AMP that was induced by this agent. Although isobutylmethylxanthine and dibutyryl cyclic AMP augment cell cyclic AMP and decrease methotrexate influx, they have different effects on efflux and net transport of methotrexate. Isobutylmethylxanthine stimulates net methotrexate uptake and slows methotrexate efflux but dibutyryl cyclic AMP depresses net methotrexate uptake without an effect on methotrexate efflux. Azide markedly stimulates methotrexate influx and net transport without a change in cell cyclic AMP. Dinitrophenol inhibits methotrexate influx and augments net methotrexate accumulation but does not alter cell cyclic AMP.

Original languageEnglish (US)
Pages (from-to)2400-2404
Number of pages5
JournalCancer Research
Volume40
Issue number7
StatePublished - 1980
Externally publishedYes

Fingerprint

Ehrlich Tumor Carcinoma
Methotrexate
Adenosine
Membranes
Dinitrophenols
Azides
Poisons
Cholera Toxin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Relationship between membrane transport of methotrexate and endogenous cyclic adenosine 3' : 5'-monophosphate in the Ehrlich ascites tumor. / White, J. C.; Carchman, R. A.; Fry, D. W.; Goldman, I. David.

In: Cancer Research, Vol. 40, No. 7, 1980, p. 2400-2404.

Research output: Contribution to journalArticle

@article{2b5c10af3ec44f78bad3b7cfe28d6187,
title = "Relationship between membrane transport of methotrexate and endogenous cyclic adenosine 3': 5'-monophosphate in the Ehrlich ascites tumor",
abstract = "Transport of methotrexate in mammalian cells is a complex process. Although the drug is pumped uphill into cells, metabolic poisons enhance influx and transmembrane gradients for this agent. Structurally unrelated inorganic and organic anions nonspecifically depress these parameters in a variety of tumor cells. It has been suggested that cell cyclic adenosine 3':5'-monophosphate (cyclic AMP) plays a regulatory role in the transport of this agent. To evaluate this further, a number of different experimental approaches were used to analyze the relationship between methotrexate transport and cell cyclic AMP in the Ehrlich ascites tumor. The following results indicate that for the Ehrlich ascites tumor, at least, there is no evidence for a regulatory role for cyclic AMP in the transport of methotrexate. A marked increase in cell cyclic AMP by cholera toxin or reduction in cyclic AMP by ascorbate was unaccompanied by changes in methotrexate influx. Instantaneous and constant inhibition of methotrexate influx by isobutylmethylxanthine was temporally dissociated from the slower rise in cell cyclic AMP that was induced by this agent. Although isobutylmethylxanthine and dibutyryl cyclic AMP augment cell cyclic AMP and decrease methotrexate influx, they have different effects on efflux and net transport of methotrexate. Isobutylmethylxanthine stimulates net methotrexate uptake and slows methotrexate efflux but dibutyryl cyclic AMP depresses net methotrexate uptake without an effect on methotrexate efflux. Azide markedly stimulates methotrexate influx and net transport without a change in cell cyclic AMP. Dinitrophenol inhibits methotrexate influx and augments net methotrexate accumulation but does not alter cell cyclic AMP.",
author = "White, {J. C.} and Carchman, {R. A.} and Fry, {D. W.} and Goldman, {I. David}",
year = "1980",
language = "English (US)",
volume = "40",
pages = "2400--2404",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Relationship between membrane transport of methotrexate and endogenous cyclic adenosine 3'

T2 - 5'-monophosphate in the Ehrlich ascites tumor

AU - White, J. C.

AU - Carchman, R. A.

AU - Fry, D. W.

AU - Goldman, I. David

PY - 1980

Y1 - 1980

N2 - Transport of methotrexate in mammalian cells is a complex process. Although the drug is pumped uphill into cells, metabolic poisons enhance influx and transmembrane gradients for this agent. Structurally unrelated inorganic and organic anions nonspecifically depress these parameters in a variety of tumor cells. It has been suggested that cell cyclic adenosine 3':5'-monophosphate (cyclic AMP) plays a regulatory role in the transport of this agent. To evaluate this further, a number of different experimental approaches were used to analyze the relationship between methotrexate transport and cell cyclic AMP in the Ehrlich ascites tumor. The following results indicate that for the Ehrlich ascites tumor, at least, there is no evidence for a regulatory role for cyclic AMP in the transport of methotrexate. A marked increase in cell cyclic AMP by cholera toxin or reduction in cyclic AMP by ascorbate was unaccompanied by changes in methotrexate influx. Instantaneous and constant inhibition of methotrexate influx by isobutylmethylxanthine was temporally dissociated from the slower rise in cell cyclic AMP that was induced by this agent. Although isobutylmethylxanthine and dibutyryl cyclic AMP augment cell cyclic AMP and decrease methotrexate influx, they have different effects on efflux and net transport of methotrexate. Isobutylmethylxanthine stimulates net methotrexate uptake and slows methotrexate efflux but dibutyryl cyclic AMP depresses net methotrexate uptake without an effect on methotrexate efflux. Azide markedly stimulates methotrexate influx and net transport without a change in cell cyclic AMP. Dinitrophenol inhibits methotrexate influx and augments net methotrexate accumulation but does not alter cell cyclic AMP.

AB - Transport of methotrexate in mammalian cells is a complex process. Although the drug is pumped uphill into cells, metabolic poisons enhance influx and transmembrane gradients for this agent. Structurally unrelated inorganic and organic anions nonspecifically depress these parameters in a variety of tumor cells. It has been suggested that cell cyclic adenosine 3':5'-monophosphate (cyclic AMP) plays a regulatory role in the transport of this agent. To evaluate this further, a number of different experimental approaches were used to analyze the relationship between methotrexate transport and cell cyclic AMP in the Ehrlich ascites tumor. The following results indicate that for the Ehrlich ascites tumor, at least, there is no evidence for a regulatory role for cyclic AMP in the transport of methotrexate. A marked increase in cell cyclic AMP by cholera toxin or reduction in cyclic AMP by ascorbate was unaccompanied by changes in methotrexate influx. Instantaneous and constant inhibition of methotrexate influx by isobutylmethylxanthine was temporally dissociated from the slower rise in cell cyclic AMP that was induced by this agent. Although isobutylmethylxanthine and dibutyryl cyclic AMP augment cell cyclic AMP and decrease methotrexate influx, they have different effects on efflux and net transport of methotrexate. Isobutylmethylxanthine stimulates net methotrexate uptake and slows methotrexate efflux but dibutyryl cyclic AMP depresses net methotrexate uptake without an effect on methotrexate efflux. Azide markedly stimulates methotrexate influx and net transport without a change in cell cyclic AMP. Dinitrophenol inhibits methotrexate influx and augments net methotrexate accumulation but does not alter cell cyclic AMP.

UR - http://www.scopus.com/inward/record.url?scp=0018861917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018861917&partnerID=8YFLogxK

M3 - Article

VL - 40

SP - 2400

EP - 2404

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 7

ER -